Morningstar1mon
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE mark certification in August 2024, is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying ...
The Scientist4y
New Transcreener CD73 Assay for Discovery of Therapeutics to Enhance Tumor Immunity
Researchers at BellBrook Labs have developed a high throughput screening (HTS) assay to discover small molecule modulators for the immunosuppressive ectonucleotidase, CD73. The Transcreener ADO CD73 ...
PharmiWeb10d
CD Formulation Now Offers One-stop Solution to Help Commercialize Cosmetics Products Faster
CD Formulation enables rapid product development success for the cosmetics industry through its complete one-stop solution as a top-tier biotechnology R&D company. Based in New York, CD Formulation ...
The Victoria Advocate1mon
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE ...
WOOD-TV1mon
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ -- AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac ...
Mena FN1mon
Alivedx Announces US FDA 510(K) Submission For Mosaiq Aiplex® Celiac Disease (CD) Multiplex Microarray
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ -- AliveDx ...